In the tumor cohort, heightened PSMD14 expression was observed in DCs, tissue stem cells, endothelial cells, and epithelial cells, contrasting sharply with the limited expression noted in the control group, which emphasizes the potential role of PSMD14 in modulating the immune microenvironment. Here, PSMD14 is linked to neoplasm.